Evoke plc (LON:EVOK – Get Free Report) shares dropped 10% during trading on Thursday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares traded hands during trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Wall Street Analyst Weigh In
Several equities research analysts have weighed in on EVOK shares. Berenberg Bank dropped their price objective on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating for the company in a report on Wednesday, December 4th. Jefferies Financial Group reiterated a “buy” rating and issued a GBX 140 ($1.81) price target on shares of Evoke in a report on Monday, December 16th.
View Our Latest Research Report on Evoke
Evoke Price Performance
Evoke (LON:EVOK – Get Free Report) last announced its quarterly earnings data on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. On average, equities analysts anticipate that Evoke plc will post 12.7648305 EPS for the current year.
Insider Activity at Evoke
In related news, insider Andrea Gisle Joosen purchased 14,572 shares of Evoke stock in a transaction dated Tuesday, January 28th. The stock was purchased at an average cost of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,202.69). 27.00% of the stock is owned by corporate insiders.
Evoke Company Profile
Recommended Stories
- Five stocks we like better than Evoke
- How to Short Nasdaq: An Easy-to-Follow Guide
- MarketBeat Week in Review – 03/24 – 03/28
- What is a buyback in stocks? A comprehensive guide for investors
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- What Are Some of the Best Large-Cap Stocks to Buy?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.